<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000514449"><TermName>PR-104</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. PR-104 becomes active when cancer cells don’t receive enough oxygen. It may kill cancer cells by damaging their DNA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>PR-104</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. PR-104 se activa cuando las células cancerosas no reciben suficiente oxígeno. Puede destruir las células cancerosas al dañar su ADN.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-02-12</DateFirstPublished></GlossaryTerm>
